twitter Tweet

OHSU research team joins elite consortium dedicated to curing Type 1 diabetes

Markus Grompe, M.D.Oregon Health & Science University’s Markus Grompe, MD, Department of Pediatrics, will lead a multi-center team of scientists selected to participate in the prestigious Beta Cell Biology Consortium (BCBC). Funded by the National Institute of Diabetes and Digestive and Kidney Diseases, the consortium’s long-term goal is to develop a cell-based therapy for insulin delivery in type 1 diabetes patients.

“The goal of our work is to produce abundant quantities of functional human insulin-producing beta cells that can be used for transplantation to cure patients with type 1 diabetes. Our group in particular is focused on novel sources for transplantable beta cell replacements,” said Grompe, principal investigator and director of the Papé Family Pediatric Research Institute, OHSU Doernbecher Children’s Hospital; and director of the Oregon Stem Cell Center at OHSU.

Pictured: Markus Grompe, M.D.

Read the OHSU Press Release

Previous Story Highlights in Nursing funding Next Story 50th anniversary of Dr. Starr's first successful artificial mitral valve implant
Facebook Twitter LinkedIn YouTube Instagram OHSU Braille services OHSU sign language services OHSU interpreter services X